Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
New Microbes and New Infections|June 18, 2015
Dolutegravir-based antiretroviral therapy in a severely overweight child with a multidrug-resistant human immunodeficiency virus infection. A case report and reviewN Wagner, C A Wyler-Lazarevic, S Yerly, et al.New Microbes and New Infections|June 4, 2016
Corrigendum to "Dolutegravir-based antiretroviral therapy in a severely overweight child with a multi-drug resistant human immunodeficiency virus infection. A case report and review" [New Microbes New Infect] 6 (2015) 1-4]N Wagner, C A Wyler-Lazarevic, S Yerly, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 20, 2017
Comparative analysis of viral shedding in pediatric and adult subjects with central nervous system-associated enterovirus infections from 2013 to 2015 in SwitzerlandS Cordey, M Schibler, A G L'Huillier, et al.The Journal of Antimicrobial Chemotherapy|September 15, 2016
Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infectionJ Ambrosioni, D Nicolás, C Manzardo, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 7, 2018
Evaluation of the Xpert MTB/RIF assay for the diagnosis of smear-negative pulmonary and extrapulmonary tuberculosis in MadagascarR Rakotoarivelo, J Ambrosioni, V Rasolofo, et al.Current Infectious Disease Reports|April 13, 2017
The Changing Epidemiology of Infective Endocarditis in the Twenty-First CenturyJ Ambrosioni, M Hernandez-Meneses, A Téllez, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 7, 2015
Toscana virus meningitis case in Switzerland: an example of the ezVIR bioinformatics pipeline utility for the identification of emerging virusesS Cordey, M Bel, T J Petty, et al.HIV Medicine|January 29, 2019
Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohortJ M Llibre, A Montoliu, J M Miró, et al.European Heart Journal|June 9, 2020
COVID-19: from epidemiology to treatmentJ M Pericàs, M Hernandez-Meneses, T P Sheahan, et al.HIV Medicine|March 2, 2018
Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0L Ryom, C Boesecke, M Bracchi, et al.Pageof 3